3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
5
Lung Neoplasms
5
Mouth Neoplasms
4
Mesothelioma, Malignant
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Interventions
Specimen Handling
3
fludarabine
2
aldesleukin
2
Sunitinib
2
Fluorouracil
2
Cyclophosphamide
2
Bevacizumab
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Tomography, X-Ray Computed
1
Radiosurgery
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Isosorbide
1
Irinotecan
1
Interleukin-2
1
IDRX-42
1
High-Intensity Interval Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Platinum
×
30 days
×
Clear all
No trials found.